Insider Buying Alert Joseph Mccracken Acquires 20,000 Shares of Savara Inc
SVRA Stock | USD 3.47 0.01 0.29% |
About 56% of Savara's investor base is looking to short. The analysis of the overall investor sentiment regarding Savara Inc suggests that many traders are alarmed. The current market sentiment, together with Savara's historical and current headlines, can help investors time the market. In addition, many technical investors use Savara Inc stock news signals to limit their universe of possible portfolio assets.
Savara |
On November 19, 2024, Joseph Mccracken, a Director at Savara Inc , purchased 20,000 shares of the company. Following this transaction, the insider now hol
Read at gurufocus.com
Savara Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards Savara can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Savara Fundamental Analysis
We analyze Savara's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Savara using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Savara based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Net Income
Net Income Comparative Analysis
Savara is currently under evaluation in net income category among its peers. Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.
Savara Inc Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Savara stock to make a market-neutral strategy. Peer analysis of Savara could also be used in its relative valuation, which is a method of valuing Savara by comparing valuation metrics with similar companies.
Peers
Savara Related Equities
DYN | Dyne Therapeutics | 6.50 | ||||
RZLT | Rezolute | 4.18 | ||||
TARA | Protara Therapeutics | 3.40 | ||||
SRRK | Scholar Rock | 2.94 | ||||
TRDA | Entrada Therapeutics | 2.37 | ||||
XLO | Xilio Development | 2.02 | ||||
CRNX | Crinetics Pharmaceuticals | 1.59 | ||||
STOK | Stoke Therapeutics | 1.19 | ||||
EWTX | Edgewise Therapeutics | 0.37 | ||||
XOMAO | XOMA | 0.36 | ||||
GPCR | Structure Therapeutics | 0.03 | ||||
LBPH | Longboard Pharmaceuticals | 0.02 | ||||
ACLX | Arcellx | 0.00 | ||||
RVMD | Revolution Medicines | 0.09 | ||||
KZR | Kezar Life | 0.40 | ||||
FENC | Fennec Pharmaceuticals | 0.50 | ||||
ANAB | AnaptysBio | 0.51 | ||||
IKNA | Ikena Oncology | 1.17 | ||||
ALXO | Alx Oncology | 1.32 | ||||
AVTE | Aerovate Therapeutics | 1.49 | ||||
TPST | Tempest Therapeutics | 1.86 | ||||
XOMA | XOMA Corp | 2.10 | ||||
PTIX | Protagenic Therapeutics | 17.81 |
Complementary Tools for Savara Stock analysis
When running Savara's price analysis, check to measure Savara's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Savara is operating at the current time. Most of Savara's value examination focuses on studying past and present price action to predict the probability of Savara's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Savara's price. Additionally, you may evaluate how the addition of Savara to your portfolios can decrease your overall portfolio volatility.
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins |